Indrayani Biotech Ltd — Important, 28-04-2026: Company Update

Indrayani Biotech's Rights Issue Committee has approved the Letter of Offer (LOF) and the Abridged Letter of Offer (ALOF). The committee also approved the format of the Composite Application Form (CAF) along with detailed instructions for the renunciation process. This signifies a key development for the company's proposed Rights Issue, as crucial documents required for the capital raising initiative are now in place, moving the process forward for shareholders.